How This CRISPR Biotech Could Make Investors Rich Post author:Sam Post published:December 26, 2017 Post category:BioPharma A look at a biotech company that represents a solid trend in the industry. Source: BioSpace You Might Also Like FDA Calls AstraZeneca PLC and MedImmune???s Imfinzi a Breakthrough July 30, 2017 Merck & Co. Scraps Experimental Cholesterol Drug Anacetrapib October 11, 2017 Ignyta To Present At 2016 Healthcare Conference July 8, 2016
